Fresenius Kabi recalls lot of Simplist morphine syringes over Dilaudid label mix-up

• Fresenius subsidiary Fresenius Kabi launched a voluntary nationwide recall of one lot of Morphine Sulfate Injection USP Simplist 2 mg/1 mL.
• Labeling mix-up: a MicroVault labeled as morphine may contain a Dilaudid (hydromorphone) 0.5 mg/0.5 mL prefilled syringe.
• Recalled morphine lot 6402820, expiration 12/2028; distributed nationwide to distributors and wholesalers.
• Mix-up carries a risk of serious harm, including life-threatening respiratory depression and death; no adverse events reported for the lot.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fresenius SE & Co. KGaA published the original content used to generate this news brief via Business Wire (Ref. ID: 202608041344BIZWIRE_USPR_____20260804_BW957631) on August 04, 2026, and is solely responsible for the information contained therein.